134 related articles for article (PubMed ID: 38301486)
1. Phage-mediated colistin resistance in Acinetobacter baumannii.
Lucidi M; Imperi F; Artuso I; Capecchi G; Spagnoli C; Visaggio D; Rampioni G; Leoni L; Visca P
Drug Resist Updat; 2024 Mar; 73():101061. PubMed ID: 38301486
[TBL] [Abstract][Full Text] [Related]
2. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
[TBL] [Abstract][Full Text] [Related]
3. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
4. Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
Yoon EJ; Kim HS; Woo H; Choi YJ; Won D; Choi JR; Kim YA; Jeong SH
J Antimicrob Chemother; 2021 Dec; 77(1):69-73. PubMed ID: 34609499
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
Haeili M; Kafshdouz M; Feizabadi MM
Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
Kim Y; Bae IK; Jeong SH; Yong D; Lee K
Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
[TBL] [Abstract][Full Text] [Related]
7. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
[TBL] [Abstract][Full Text] [Related]
8.
Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Novel
Gerson S; Betts JW; Lucaßen K; Nodari CS; Wille J; Josten M; Göttig S; Nowak J; Stefanik D; Roca I; Vila J; Cisneros JM; La Ragione RM; Seifert H; Higgins PG
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617096
[TBL] [Abstract][Full Text] [Related]
10. Colistin-phage combinations decrease antibiotic resistance in
Wang X; Loh B; Gordillo Altamirano F; Yu Y; Hua X; Leptihn S
Emerg Microbes Infect; 2021 Dec; 10(1):2205-2219. PubMed ID: 34736365
[TBL] [Abstract][Full Text] [Related]
11. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
Boinett CJ; Cain AK; Hawkey J; Do Hoang NT; Khanh NNT; Thanh DP; Dordel J; Campbell JI; Lan NPH; Mayho M; Langridge GC; Hadfield J; Chau NVV; Thwaites GE; Parkhill J; Thomson NR; Holt KE; Baker S
Microb Genom; 2019 Feb; 5(2):. PubMed ID: 30720421
[TBL] [Abstract][Full Text] [Related]
13. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
[TBL] [Abstract][Full Text] [Related]
14. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
[TBL] [Abstract][Full Text] [Related]
15. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
16. Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.
Rolain JM; Diene SM; Kempf M; Gimenez G; Robert C; Raoult D
Antimicrob Agents Chemother; 2013 Jan; 57(1):592-6. PubMed ID: 23070160
[TBL] [Abstract][Full Text] [Related]
17. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.
Potron A; Vuillemenot JB; Puja H; Triponney P; Bour M; Valot B; Amara M; Cavalié L; Bernard C; Parmeland L; Reibel F; Larrouy-Maumus G; Dortet L; Bonnin RA; Plésiat P
J Antimicrob Chemother; 2019 Sep; 74(9):2544-2550. PubMed ID: 31199431
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
[TBL] [Abstract][Full Text] [Related]
19. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
